Skip to main content
OpenTrials
Completed

NCT Number: NCT01237314

The Impact of Food on Blood Sugar in People With Type 2 Diabetes

This study will record the impact of food on blood glucose levels using continuous glucose monitoring (CGM).

The investigators think the impact will improve as medication doses are adjusted. The investigators also think that the impact will differ depending on the type of medication taken.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Type 2 Diabetes Diabetes Mellitus Diabetes Mellitus, Type 2 Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

International Diabetes Center

Minneapolis, Minnesota, 55416, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Study participants who are consented for the primary study and have not yet done the baseline CGM data collection at week -2-0.

Exclusion criteria

  • Study participants who are unable to complete the baseline CGM data collection at week -2-0.
  • Study participants who are allergic to or have a food intolerance to any of the foods in the fixed meal

Treatment and study plan

Primary outcomes

  1. 4-hour glycemic response at 3 time points

    Time frame: 4 hours

    The four-hour glycemic response includes: four-hour post-meal area under the median interstitial glucose curve, post-meal interstitial glucose peak, time to peak, time to return to pre-prandial level (to within 10% of baseline with a maximum of the 4-hour post-meal fast), difference between peak and baseline, average rate of change in interstitial glucose across the 4 hour post-meal period, and percent of the 4-hour post-meal glucose readings >180 mg/dL.

Sponsors and collaborators

Lead sponsor

HealthPartners Institute

Other

Collaborators

  • International Diabetes Center at Park Nicollet
  • Sanofi

Registry information

Official study title

Evaluation of the Glycemic Impact of Food in Patients With Type 2 Diabetes Taking Glargine and/or Exenatide

Acronym: REACT2

Important dates

Study start
2010
Primary completion
2013
Study completion
2013
First posted
Nov 9, 2010
Registry last updated
Dec 2, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.